1. The Role of Nuclear β-Catenin Accumulation in the Twist2-Induced Ovarian Cancer EMT
   Yubin Mao et al, 2013, PLoS ONE CrossRef
2. Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
   Denis Lane et al, 2013, Journal of Ovarian Research CrossRef
3. TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth
   Maria-Vittoria Sepporta et al, 2022, Communications Biology CrossRef
4. TWIST mediates resistance to paclitaxel by regulating Akt and Bcl-2 expression in gastric cancer cells
   Chae Hwa Kwon et al, 2017, Tumor Biology CrossRef
5. The therapeutic potential of targeting the epithelial–mesenchymal transition in cancer
   Kevin R Ginnebaugh et al, 2014, Expert Opinion on Therapeutic Targets CrossRef
6. Epithelial‐mesenchymal transition during invasion of cutaneous squamous cell carcinoma is paralleled by AKT activation
   K. Barrette et al, 2014, British Journal of Dermatology CrossRef
7. The correlation between Twist 1 and 2 promoter methylation status and clinicopathologic characteristics of patients with breast cancer
   Maryam Fattahi et al, 2020, Gene Reports CrossRef
8. Phenotypic Plasticity and the Origins and Progression of Ovarian Cancer
   Lauren E. Carter et al, 2019, The Ovary CrossRef
9. Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells
   ZHIPING HE et al, 2016, Oncology Reports CrossRef